Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial)

Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial)

Background: Ureteric colic, the term used to describe the pain felt when a stone passes down the ureter from the kidney to the bladder, is a frequent reason for people to seek emergency health care. Treatment with the muscle-relaxant drugs tamsulosin hydrochloride (Petyme, TEVA UK Ltd) and nifedipin...

Full description

Bibliographic Details
Main Authors: Robert Pickard, Kathryn Starr, Graeme MacLennan, Mary Kilonzo, Thomas Lam, Ruth Thomas, Jennifer Burr, John Norrie, Gladys McPherson, Alison McDonald, Kirsty Shearer, Katie Gillies, Kenneth Anson, Charles Boachie, James N’Dow, Neil Burgess, Terry Clark, Sarah Cameron, Samuel McClinton
Format: Article
Language:English
Published: NIHR Journals Library 2015-08-01
Series:Health Technology Assessment
Subjects:
drug therapy
ureteric stones
randomised controlled trial
calcium channel blocker
nifedipine
alpha-blocker
tamsulosin
Online Access:https://doi.org/10.3310/hta19630

Internet

https://doi.org/10.3310/hta19630

Similar Items